TRANSLATIONAL RESEARCH GROUP CORE 011 ? TRANSLATIONAL PATHOLOGY SHARED RESOURCE PROJECT SUMMARY/ABSTRACT Obtaining, processing and staining of tissue specimens and quantitation of stained sections are central to the performance of modern cancer research. The Translational Pathology Shared Resource (TPSR) provides Vanderbilt-Ingram Cancer Center (VICC) investigators with a full range of pathology services and technologies to support the cancer research effort at Vanderbilt. The VICC TPSR capitalizes on Vanderbilt expertise, bringing together the capabilities of key service providers in a collaborative effort to provide a complete cancer tissue package for VICC investigators ? research histology and pathology, comparative and animal pathology and tissue acquisition ? by leveraging the capabilities of Western Division of the NCI-funded Cooperative Human Tissue Network (CHTN) and digital histology. Through a partnership with the CHTN, the TPSR coordinates the procurement and processing of human tissues obtained from both the operating room and clinical settings under IRB-approved protocols. The TPSR provides full research histopathology services, including processing, embedding, sectioning and staining of both human and animal model tissues. The TPSR also performs a wide range of automated immunostaining protocols that can be customized to investigator needs. Both paraffin and frozen sectioning of specimens can be performed for investigators. The core now houses a robotic system for automated assembly of tissue microarrays from multiple tissue blocks, which provides a superior new service. The core also provides investigators with access to laser capture microdissection instrumentation for isolation of discrete cell populations from tissue sections. As an adjunct to the array of staining and immunostaining procedures available, the TPSR offers digital imaging within a new facility, which provides automated scanning of both brightfield and fluorescence staining as well as quantitation of digital images for performance of true quantitative pathological measures. In addition to tissue resources for investigators working with animal models, the comparative pathology service also provides a full line of clinical pathology diagnostic services and pathology phenotyping of mouse models for VICC investigators. Finally, the animal and human pathologists provide consultative services in both human and veterinary pathology for cancer research investigators. The TPSR provides the full range of pathology technologies and expertise to support all aspects of cancer research related to the analysis of human tissue specimens and animal models to facilitate cancer discovery.

Public Health Relevance

TRANSLATIONAL RESEARCH GROUP CORE 011 ? TRANSLATIONAL PATHOLOGY SHARED RESOURCE PROJECT NARRATIVE Per the PAR-13-386 FOA, the project narrative is not applicable for the Translational Pathology Shared Resource.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-21
Application #
9152306
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Program Officer
Marino, Michael A
Project Start
Project End
Budget Start
2016-09-01
Budget End
2017-08-31
Support Year
21
Fiscal Year
2016
Total Cost
$299,659
Indirect Cost
$108,794
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Burns, Michael C; Howes, Jennifer E; Sun, Qi et al. (2018) High-throughput screening identifies small molecules that bind to the RAS:SOS:RAS complex and perturb RAS signaling. Anal Biochem 548:44-52
Phelps, Hannah M; Al-Jadiry, Mazin F; Corbitt, Natasha M et al. (2018) Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq. World J Pediatr 14:585-593
Liu, Qi; Herring, Charles A; Sheng, Quanhu et al. (2018) Quantitative assessment of cell population diversity in single-cell landscapes. PLoS Biol 16:e2006687
Almodovar, Karinna; Iams, Wade T; Meador, Catherine B et al. (2018) Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse. J Thorac Oncol 13:112-123
Greenplate, Allison; Wang, Kai; Tripathi, Rati M et al. (2018) Genomic Profiling of T-Cell Neoplasms Reveals Frequent JAK1 and JAK3 Mutations With Clonal Evasion From Targeted Therapies. JCO Precis Oncol 2018:
Mi, Deborah J; Dixit, Shilpy; Warner, Timothy A et al. (2018) Altered glutamate clearance in ascorbate deficient mice increases seizure susceptibility and contributes to cognitive impairment in APP/PSEN1 mice. Neurobiol Aging 71:241-254
Diggins, Kirsten E; Gandelman, Jocelyn S; Roe, Caroline E et al. (2018) Generating Quantitative Cell Identity Labels with Marker Enrichment Modeling (MEM). Curr Protoc Cytom 83:10.21.1-10.21.28
Warner, Jeremy L; Prasad, Ishaan; Bennett, Makiah et al. (2018) SMART Cancer Navigator: A Framework for Implementing ASCO Workshop Recommendations to Enable Precision Cancer Medicine. JCO Precis Oncol 2018:
Brown, Judy J; Short, Sarah P; Stencel-Baerenwald, Jennifer et al. (2018) Reovirus-Induced Apoptosis in the Intestine Limits Establishment of Enteric Infection. J Virol 92:
Iams, Wade T; Yu, Hui; Shyr, Yu et al. (2018) First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-Small-cell Lung Cancer With Different Prognostic Significance. Clin Lung Cancer 19:531-543

Showing the most recent 10 out of 2462 publications